Development of functional docetaxel nanomicelles for treatment of brain glioma
Source abstract
Abstract
The efficacy of anticancer drugs is rather limited in the treatment of brain glioma due to the hindrance of the blood-brain barrier (BBB). Herein, we reported an easy formulation of functional docetaxel nanomicelles for the treatment of brain glioma using a graft copolymer soluplus as basic material through dual-modifications with a glucose-lipid derivative and a dequalinium-lipid derivative. The studies were performed on brain glioma U87MG cells, in vitro BBB models and brain glioma-bearing nude mice. The functional docetaxel nanomicelles were approximately 100 nm. The results demonstrated that the functional docetaxel nanomicelles could transport across the BBB, enhance the cellular uptake, target to the mitochondria, induce the apoptosis, increase the cytotoxicity in the brain glioma cells, and extend survival span of the brain glioma-bearing mice. The action mechanisms were associated with dual-modifications by the glucose-lipid derivative and the dequalinium-lipid derivative, both of which are beneficial for the transport across the BBB. Furthermore, the modification with dequalinium-lipid derivative was able to target to the brain glioma cells and to the mitochondria. In conclusion, the functional docetaxel nanomicelles would be a promising formulation for the treatment of brain glioma, deserving further development for clinical trials.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Drug Transport and Resistance Mechanisms · RNA Interference and Gene Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Pharmaceutical Engineering, Beijing Institute of Petrochemical Technology
Beijing Key Laboratory of Molecular Pharmaceutics and New Drug System, State Key Laboratory of Natural and Biomimetic Drugs, and School of Pharmaceutical Sciences, Peking University
School of Pharmacy, Liaoning University of Traditional Chinese Medicine
Funding
National Natural Science Foundation of China · Beijing Municipal Education Commission
References (31)
Show source-provided references
1. 10.1016/j.ccr.2006.02.01910.1016/j.ccr.2006.02.019 ↗
2. 10.1097/00130404-200305000-0000310.1097/00130404-200305000-00003 ↗
3. 10.1038/nrc70610.1038/nrc706 ↗
4. 10.1073/pnas.86.2.69510.1073/pnas.86.2.695 ↗
5. 10.1124/pr.57.2.410.1124/pr.57.2.4 ↗
6. 10.4155/tde.15.4810.4155/tde.15.48 ↗
7. 10.1016/j.ejpb.2016.06.01510.1016/j.ejpb.2016.06.015 ↗
8. 10.1016/j.nbd.2009.07.02810.1016/j.nbd.2009.07.028 ↗
9. 10.1002/jnr.2273810.1002/jnr.22738 ↗
10. 10.1186/s12987-015-0005-y10.1186/s12987-015-0005-y ↗
11. 10.1074/jbc.272.30.1898210.1074/jbc.272.30.18982 ↗
12. 10.1016/j.biomaterials.2011.04.02910.1016/j.biomaterials.2011.04.029 ↗
13. 10.1016/j.biomaterials.2013.01.05510.1016/j.biomaterials.2013.01.055 ↗
14. Mu LM, Wu JS, Xie HJ, et al. The use of a new functional glucose conjugate material, TPGS1000-Glu, in treatment of brain glioma by incorporating into epirubicin liposomes. J Chin Pharm Sci. 2016;25: 266–274.
15. 10.2147/IJN.S9446710.2147/IJN.S94467 ↗
16. 10.1080/21691401.2018.143318710.1080/21691401.2018.1433187 ↗
17. 10.1093/neuonc/nos21810.1093/neuonc/nos218 ↗
18. 10.2147/IJN.S13825710.2147/IJN.S138257 ↗
19. 10.1038/nnano.2017.5410.1038/nnano.2017.54 ↗
20. 10.1016/j.addr.2013.08.00810.1016/j.addr.2013.08.008 ↗
21. 10.1016/j.jconrel.2009.09.02010.1016/j.jconrel.2009.09.020 ↗
22. 10.1016/j.biomaterials.2014.03.04910.1016/j.biomaterials.2014.03.049 ↗
23. 10.1016/j.ejps.2017.06.00210.1016/j.ejps.2017.06.002 ↗
24. 10.1016/j.biomaterials.2010.11.08210.1016/j.biomaterials.2010.11.082 ↗
25. 10.1016/j.ejpb.2007.03.02210.1016/j.ejpb.2007.03.022 ↗
26. 10.1016/j.colsurfb.2014.06.04610.1016/j.colsurfb.2014.06.046 ↗
27. Homayouni A, Sadeghi F, Nokhodchi A, et al. Preparation and characterization of celecoxib dispersions in soluplus(®): comparison of spray drying and conventional methods. Iran J Pharm Res. 2015;14:35–50.
28. 10.1016/j.ijpharm.2015.01.01210.1016/j.ijpharm.2015.01.012 ↗
29. 10.1371/journal.pone.001912110.1371/journal.pone.0019121 ↗
30. 10.1016/j.biomaterials.2015.02.07710.1016/j.biomaterials.2015.02.077 ↗
31. 10.1016/j.mito.2005.07.00110.1016/j.mito.2005.07.001 ↗